Early experience with therapeutic drug monitoring of vedolizumab in patients with inflammatory bowel disease

被引：0
|
作者：
Fernandez, R. [1 ]
Sanchez, G. [1 ]
Pedraza, L. [1 ]
Prieto, V. [2 ]
Calabuig, V. K. [2 ]
Fernandez, E. [1 ]
Otero, M. J. [1 ]
机构：
[1] Complejo Asistencial Univ Salamanca, Hosp Pharm, Salamanca, Spain
[2] Complejo Asistencial Univ Salamanca, Digest Unit, Salamanca, Spain
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2019年 / 41卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
TDMP003
引用
收藏
页码：361 / 362
页数：2
相关论文
共 50 条
  • [1] Therapeutic Drug Monitoring in Inflammatory Bowel Disease Patients on Vedolizumab
    Ansari, Mohammed
    Glassner, Kerri
    Irani, Malcolm
    Perry, Caroline
    Abraham, Bincy P.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S435 - S436
  • [2] Therapeutic drug monitoring in inflammatory bowel disease patients on vedolizumab
    Ansari, Mohammed
    Glassner, Kerri
    Irani, Malcolm
    Saleh, Adam
    Wang, Lin
    Ezeana, Chika
    Wong, Stephen
    Perry, Caroline
    Abraham, Bincy
    JOURNAL OF DIGESTIVE DISEASES, 2024, 25 (02) : 91 - 99
  • [3] REAL WORLD EXPERIENCE IN THERAPEUTIC DRUG MONITORING IN INFLAMMATORY BOWEL DISEASE PATIENTS ON VEDOLIZUMAB
    Glassner, Kerri
    Irani, Malcolm
    Malaty, Hoda
    Abraham, Bincy P.
    GASTROENTEROLOGY, 2019, 156 (03) : S36 - S37
  • [4] THERAPEUTIC DRUG MONITORING OF VEDOLIZUMAB FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE: REAL WORLD EXPERIENCE
    Shalabi, Ahmed
    Banerjee, Rwiti
    Padley, Jessica
    Appleby, Richard
    Johnston, Emma
    GUT, 2021, 70 : A120 - A120
  • [5] REAL WORLD EXPERIENCE IN THERAPEUTIC DRUG MONITORING IN INFLAMMATORY BOWEL DISEASE PATIENTS ON VEDOLIZUMAB
    Glassner, Kerri
    Irani, Malcolm
    Malaty, Hoda
    Abraham, Bincy P.
    INFLAMMATORY BOWEL DISEASES, 2019, 25 : S26 - S26
  • [6] Therapeutic drug monitoring of vedolizumab in inflammatory bowel disease
    Torres, N.
    Martin Arranz, D.
    Sanchez Azofra, M.
    Martin Arranz, E.
    Garcia, L.
    Nozal, P.
    Pascual, J.
    Apraiz, I.
    Lopez, M.
    Arteta, D.
    Nagore, D.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S387 - S387
  • [7] Therapeutic drug monitoring with vedolizumab in inflammatory bowel disease.
    Pugliese, Daniela
    Privitera, Giuseppe
    Pizzolante, Fabrizio
    Gasbarrini, Antonio
    Guidi, Luisa
    Armuzzi, Alessandro
    MINERVA GASTROENTEROLOGICA E DIETOLOGICA, 2019, 65 (04) : 280 - 290
  • [8] Therapeutic Drug Monitoring With Ustekinumab and Vedolizumab in Inflammatory Bowel Disease
    Restellini, Sophie
    Khanna, Reena
    Afif, Waqqas
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (10) : 2165 - 2172
  • [9] Therapeutic drug monitoring of vedolizumab therapy in inflammatory bowel disease
    Steenholdt, Casper
    Lorentsen, Ruben Due
    Petersen, Pernille Norgaard
    Widigson, Ella S. K.
    Kloft, Charlotte
    Klaasen, Rolf Anton
    Brynskov, Jorn
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (06) : 1088 - 1098
  • [10] The use of therapeutic drug monitoring for early identification of vedolizumab response in Saudi Arabian patients with inflammatory bowel disease
    Anbarserry, Doaa
    Mosli, Mahmoud
    Qari, Yousef
    Saadah, Omar
    Bokhary, Rana
    Esmat, Ahmed
    Alsieni, Mohammed
    Shaker, Ahmed
    Elango, Ramu
    Alharthi, Sameer
    SCIENTIFIC REPORTS, 2023, 13 (01)
12345